CVS Health (NYSE:CVS) finance chief Thomas Cowhey is set to step down amid the company's ongoing turnaround efforts led by ...

CVS Health's chief financial officer, Thomas Cowhey, intends to step down, Bloomberg News reported on Monday, amid the health ...

CVS Health Corp Chief Financial Officer Thomas Cowhey intends to step down from his position, Bloomberg News reported on ...

CVS faces pressures from rising medical costs, but promising guidance, stable finances, and low valuations suggest strong ...

CVS Health CEO David Joyner earned $17.8 million in total compensation in 2024. The company reported compensation data for its six highest-paid executives in its annual proxy report, published April 4 ...

In a report released today, Charles Rhyee from TD Cowen reiterated a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

A woman says a popular CVS supplement caused her to be sent to the hospital with organ failure. Here's what you need to know.

One quarter into 2025, CVS Health has risen the most of any stock in the S&P 500, with a share price that has popped 50% ...

Shares of CVS Health climbed 6.5%, to $68, in after-hours trading, while shares of UnitedHealth Group rose 6%, to $556. Spire Global reached an agreement with Kpler regarding a disputed deal for the ...

In a motion to dismiss most claims, attorneys for the Woonsocket, R.I.-based company argue the DOJ failed to provide key ...

CVS Health is a BUY. Undervalued with growth potential, it outshines competitors despite sector challenges. See more on CVS ...

CVS Health Corp. continues to fight a civil lawsuit that accuses the corporation and its retail pharmacists of wrongfully ...